<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d216" origId="Felodipine"><sentence id="DrugDDI.d216.s0" origId="s0" text="CYP3A4 Inhibitors?Felodipine is metabolized by CYP3A4."><entity charOffset="0-6" id="DrugDDI.d216.s0.e0" origId="s0.p0" text="CYP3A4" type="drug"/><entity charOffset="47-53" id="DrugDDI.d216.s0.e1" origId="s0.p3" text="CYP3A4" type="drug"/><pair e1="DrugDDI.d216.s0.e0" e2="DrugDDI.d216.s0.e1" id="DrugDDI.d216.s0.p0" interaction="true"/></sentence><sentence id="DrugDDI.d216.s1" origId="s1" text="Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism."><entity charOffset="21-27" id="DrugDDI.d216.s1.e0" origId="s1.p5" text="CYP3A4" type="drug"/><entity charOffset="44-56" id="DrugDDI.d216.s1.e1" origId="s1.p8" text="ketoconazole" type="drug"/><entity charOffset="58-70" id="DrugDDI.d216.s1.e2" origId="s1.p9" text="itraconazole" type="drug"/><entity charOffset="72-84" id="DrugDDI.d216.s1.e3" origId="s1.p10" text="erythromycin" type="drug"/><entity charOffset="104-114" id="DrugDDI.d216.s1.e4" origId="s1.p12" text="cimetidine" type="drug"/><entity charOffset="121-131" id="DrugDDI.d216.s1.e5" origId="s1.p14" text="felodipine" type="drug"/><entity charOffset="192-202" id="DrugDDI.d216.s1.e6" origId="s1.p20" text="felodipine" type="drug"/><pair e1="DrugDDI.d216.s1.e0" e2="DrugDDI.d216.s1.e1" id="DrugDDI.d216.s1.p0" interaction="false"/><pair e1="DrugDDI.d216.s1.e0" e2="DrugDDI.d216.s1.e2" id="DrugDDI.d216.s1.p1" interaction="false"/><pair e1="DrugDDI.d216.s1.e0" e2="DrugDDI.d216.s1.e3" id="DrugDDI.d216.s1.p2" interaction="false"/><pair e1="DrugDDI.d216.s1.e0" e2="DrugDDI.d216.s1.e4" id="DrugDDI.d216.s1.p3" interaction="false"/><pair e1="DrugDDI.d216.s1.e0" e2="DrugDDI.d216.s1.e5" id="DrugDDI.d216.s1.p4" interaction="true"/><pair e1="DrugDDI.d216.s1.e0" e2="DrugDDI.d216.s1.e6" id="DrugDDI.d216.s1.p5" interaction="false"/><pair e1="DrugDDI.d216.s1.e1" e2="DrugDDI.d216.s1.e2" id="DrugDDI.d216.s1.p6" interaction="false"/><pair e1="DrugDDI.d216.s1.e1" e2="DrugDDI.d216.s1.e3" id="DrugDDI.d216.s1.p7" interaction="false"/><pair e1="DrugDDI.d216.s1.e1" e2="DrugDDI.d216.s1.e4" id="DrugDDI.d216.s1.p8" interaction="false"/><pair e1="DrugDDI.d216.s1.e1" e2="DrugDDI.d216.s1.e5" id="DrugDDI.d216.s1.p9" interaction="true"/><pair e1="DrugDDI.d216.s1.e1" e2="DrugDDI.d216.s1.e6" id="DrugDDI.d216.s1.p10" interaction="false"/><pair e1="DrugDDI.d216.s1.e2" e2="DrugDDI.d216.s1.e3" id="DrugDDI.d216.s1.p11" interaction="false"/><pair e1="DrugDDI.d216.s1.e2" e2="DrugDDI.d216.s1.e4" id="DrugDDI.d216.s1.p12" interaction="false"/><pair e1="DrugDDI.d216.s1.e2" e2="DrugDDI.d216.s1.e5" id="DrugDDI.d216.s1.p13" interaction="true"/><pair e1="DrugDDI.d216.s1.e2" e2="DrugDDI.d216.s1.e6" id="DrugDDI.d216.s1.p14" interaction="false"/><pair e1="DrugDDI.d216.s1.e3" e2="DrugDDI.d216.s1.e4" id="DrugDDI.d216.s1.p15" interaction="false"/><pair e1="DrugDDI.d216.s1.e3" e2="DrugDDI.d216.s1.e5" id="DrugDDI.d216.s1.p16" interaction="true"/><pair e1="DrugDDI.d216.s1.e3" e2="DrugDDI.d216.s1.e6" id="DrugDDI.d216.s1.p17" interaction="false"/><pair e1="DrugDDI.d216.s1.e4" e2="DrugDDI.d216.s1.e5" id="DrugDDI.d216.s1.p18" interaction="true"/><pair e1="DrugDDI.d216.s1.e4" e2="DrugDDI.d216.s1.e6" id="DrugDDI.d216.s1.p19" interaction="false"/><pair e1="DrugDDI.d216.s1.e5" e2="DrugDDI.d216.s1.e6" id="DrugDDI.d216.s1.p20" interaction="false"/></sentence><sentence id="DrugDDI.d216.s2" origId="s2" text="These increases in concentration may lead to increased effects, (lower blood pressure and increased heart rate)."/><sentence id="DrugDDI.d216.s3" origId="s3" text="These effects have been observed with co-administration of itraconazole (a potent CYP3A4 inhibitor)."><entity charOffset="59-71" id="DrugDDI.d216.s3.e0" origId="s3.p42" text="itraconazole" type="drug"/><entity charOffset="82-88" id="DrugDDI.d216.s3.e1" origId="s3.p44" text="CYP3A4" type="drug"/><pair e1="DrugDDI.d216.s3.e0" e2="DrugDDI.d216.s3.e1" id="DrugDDI.d216.s3.p0" interaction="false"/></sentence><sentence id="DrugDDI.d216.s4" origId="s4" text="Caution should be used when CYP3A4 inhibitors are co-administered with felodipine."><entity charOffset="28-34" id="DrugDDI.d216.s4.e0" origId="s4.p51" text="CYP3A4" type="drug"/><entity charOffset="71-81" id="DrugDDI.d216.s4.e1" origId="s4.p54" text="felodipine" type="drug"/><pair e1="DrugDDI.d216.s4.e0" e2="DrugDDI.d216.s4.e1" id="DrugDDI.d216.s4.p0" interaction="true"/></sentence><sentence id="DrugDDI.d216.s5" origId="s5" text="A conservative approach to dosing felodipine should be taken."><entity charOffset="34-44" id="DrugDDI.d216.s5.e0" origId="s5.p56" text="felodipine" type="drug"/></sentence><sentence id="DrugDDI.d216.s6" origId="s6" text="The following specific interactions have been reported: Itraconazole?Co-administration of another extended release formulation of felodipine with itraconazole resulted in approximately 8-fold increase in the AUC, more than 6- fold increase in the Cmax, and 2-fold prolongation in the half- life of felodipine."><entity charOffset="130-140" id="DrugDDI.d216.s6.e0" origId="s6.p67" text="felodipine" type="drug"/><entity charOffset="146-158" id="DrugDDI.d216.s6.e1" origId="s6.p68" text="itraconazole" type="drug"/><entity charOffset="298-308" id="DrugDDI.d216.s6.e2" origId="s6.p78" text="felodipine" type="drug"/><pair e1="DrugDDI.d216.s6.e0" e2="DrugDDI.d216.s6.e1" id="DrugDDI.d216.s6.p0" interaction="true"/><pair e1="DrugDDI.d216.s6.e0" e2="DrugDDI.d216.s6.e2" id="DrugDDI.d216.s6.p1" interaction="false"/><pair e1="DrugDDI.d216.s6.e1" e2="DrugDDI.d216.s6.e2" id="DrugDDI.d216.s6.p2" interaction="false"/></sentence><sentence id="DrugDDI.d216.s7" origId="s7" text="Erythromycin?Co-administration of felodipine (PLENDIL) with erythromycin resulted in approximately 2.5- fold increase in the AUC and Cmax, and about 2- fold prolongation in the half- life of felodipine."><entity charOffset="34-44" id="DrugDDI.d216.s7.e0" origId="s7.p80" text="felodipine" type="drug"/><entity charOffset="46-53" id="DrugDDI.d216.s7.e1" origId="s7.p82" text="PLENDIL" type="drug"/><entity charOffset="60-72" id="DrugDDI.d216.s7.e2" origId="s7.p84" text="erythromycin" type="drug"/><entity charOffset="191-201" id="DrugDDI.d216.s7.e3" origId="s7.p93" text="felodipine" type="drug"/><pair e1="DrugDDI.d216.s7.e0" e2="DrugDDI.d216.s7.e1" id="DrugDDI.d216.s7.p0" interaction="false"/><pair e1="DrugDDI.d216.s7.e0" e2="DrugDDI.d216.s7.e2" id="DrugDDI.d216.s7.p1" interaction="true"/><pair e1="DrugDDI.d216.s7.e0" e2="DrugDDI.d216.s7.e3" id="DrugDDI.d216.s7.p2" interaction="false"/><pair e1="DrugDDI.d216.s7.e1" e2="DrugDDI.d216.s7.e2" id="DrugDDI.d216.s7.p3" interaction="true"/><pair e1="DrugDDI.d216.s7.e1" e2="DrugDDI.d216.s7.e3" id="DrugDDI.d216.s7.p4" interaction="false"/><pair e1="DrugDDI.d216.s7.e2" e2="DrugDDI.d216.s7.e3" id="DrugDDI.d216.s7.p5" interaction="false"/></sentence><sentence id="DrugDDI.d216.s8" origId="s8" text="Grapefruit juice?Co-administration of felodipine with grapefruit juice resulted in more than 2-fold increase in the AUC and Cmax, but no prolongation in the half- life of felodipine."><entity charOffset="0-10" id="DrugDDI.d216.s8.e0" origId="s8.p94" text="Grapefruit" type="drug"/><entity charOffset="38-48" id="DrugDDI.d216.s8.e1" origId="s8.p95" text="felodipine" type="drug"/><entity charOffset="171-181" id="DrugDDI.d216.s8.e2" origId="s8.p104" text="felodipine" type="drug"/><pair e1="DrugDDI.d216.s8.e0" e2="DrugDDI.d216.s8.e1" id="DrugDDI.d216.s8.p0" interaction="false"/><pair e1="DrugDDI.d216.s8.e0" e2="DrugDDI.d216.s8.e2" id="DrugDDI.d216.s8.p1" interaction="false"/><pair e1="DrugDDI.d216.s8.e1" e2="DrugDDI.d216.s8.e2" id="DrugDDI.d216.s8.p2" interaction="false"/><negationtags>Grapefruit juice?Co-administration of felodipine with grapefruit juice resulted in more than 2-fold increase in the AUC and Cmax, but &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; prolongation in the half- life of felodipine&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d216.s9" origId="s9" text="Cimetidine?Co-administration of felodipine with cimetidine (a non-specific CYP-450 inhibitor) resulted in an increase of approximately 50% in the AUC and the Cmax, of felodipine."><entity charOffset="32-42" id="DrugDDI.d216.s9.e0" origId="s9.p106" text="felodipine" type="drug"/><entity charOffset="48-58" id="DrugDDI.d216.s9.e1" origId="s9.p107" text="cimetidine" type="drug"/><entity charOffset="167-177" id="DrugDDI.d216.s9.e2" origId="s9.p117" text="felodipine" type="drug"/><pair e1="DrugDDI.d216.s9.e0" e2="DrugDDI.d216.s9.e1" id="DrugDDI.d216.s9.p0" interaction="true"/><pair e1="DrugDDI.d216.s9.e0" e2="DrugDDI.d216.s9.e2" id="DrugDDI.d216.s9.p1" interaction="false"/><pair e1="DrugDDI.d216.s9.e1" e2="DrugDDI.d216.s9.e2" id="DrugDDI.d216.s9.p2" interaction="false"/></sentence><sentence id="DrugDDI.d216.s10" origId="s10" text="Beta-Blocking Agents? A pharmacokinetic study of felodipine in conjunction with metoprolol demonstrated no significant effects on the pharmacokinetics of felodipine."><entity charOffset="49-59" id="DrugDDI.d216.s10.e0" origId="s10.p120" text="felodipine" type="drug"/><entity charOffset="80-90" id="DrugDDI.d216.s10.e1" origId="s10.p121" text="metoprolol" type="drug"/><entity charOffset="154-164" id="DrugDDI.d216.s10.e2" origId="s10.p125" text="felodipine" type="drug"/><pair e1="DrugDDI.d216.s10.e0" e2="DrugDDI.d216.s10.e1" id="DrugDDI.d216.s10.p0" interaction="false"/><pair e1="DrugDDI.d216.s10.e0" e2="DrugDDI.d216.s10.e2" id="DrugDDI.d216.s10.p1" interaction="false"/><pair e1="DrugDDI.d216.s10.e1" e2="DrugDDI.d216.s10.e2" id="DrugDDI.d216.s10.p2" interaction="false"/><negationtags>Beta-Blocking Agents? A pharmacokinetic study of felodipine in conjunction with metoprolol demonstrated &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; significant effects on the pharmacokinetics of felodipine&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d216.s11" origId="s11" text="The AUC and Cmax of metoprolol, however, were increased approximately 31 and 38%, respectively."><entity charOffset="20-30" id="DrugDDI.d216.s11.e0" origId="s11.p129" text="metoprolol" type="drug"/></sentence><sentence id="DrugDDI.d216.s12" origId="s12" text="In controlled clinical trials, however, beta blockers including metoprolol were concurrently administered with felodipine and were well tolerated."><entity charOffset="40-53" id="DrugDDI.d216.s12.e0" origId="s12.p139" text="beta blockers" type="drug"/><entity charOffset="64-74" id="DrugDDI.d216.s12.e1" origId="s12.p141" text="metoprolol" type="drug"/><entity charOffset="111-121" id="DrugDDI.d216.s12.e2" origId="s12.p145" text="felodipine" type="drug"/><pair e1="DrugDDI.d216.s12.e0" e2="DrugDDI.d216.s12.e1" id="DrugDDI.d216.s12.p0" interaction="false"/><pair e1="DrugDDI.d216.s12.e0" e2="DrugDDI.d216.s12.e2" id="DrugDDI.d216.s12.p1" interaction="false"/><pair e1="DrugDDI.d216.s12.e1" e2="DrugDDI.d216.s12.e2" id="DrugDDI.d216.s12.p2" interaction="false"/></sentence><sentence id="DrugDDI.d216.s13" origId="s13" text="Digoxin? When given concomitantly with PLENDIL the pharmacokinetics of digoxin in patients with heart failure were not significantly altered."><entity charOffset="39-46" id="DrugDDI.d216.s13.e0" origId="s13.p153" text="PLENDIL" type="drug"/><entity charOffset="71-78" id="DrugDDI.d216.s13.e1" origId="s13.p155" text="digoxin" type="drug"/><pair e1="DrugDDI.d216.s13.e0" e2="DrugDDI.d216.s13.e1" id="DrugDDI.d216.s13.p0" interaction="false"/><negationtags>Digoxin? When given concomitantly with PLENDIL &lt;xcope&gt;the pharmacokinetics of digoxin in patients with heart failure were &lt;cue&gt;not&lt;/cue&gt; significantly altered&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d216.s14" origId="s14" text="Anticonvulsants? In a pharmacokinetic study, maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg, phenytoin, carbamazepine, or phenobarbital) than in healthy volunteers."><entity charOffset="78-88" id="DrugDDI.d216.s14.e0" origId="s14.p163" text="felodipine" type="drug"/><entity charOffset="176-185" id="DrugDDI.d216.s14.e1" origId="s14.p170" text="phenytoin" type="drug"/><entity charOffset="187-200" id="DrugDDI.d216.s14.e2" origId="s14.p171" text="carbamazepine" type="drug"/><entity charOffset="205-218" id="DrugDDI.d216.s14.e3" origId="s14.p173" text="phenobarbital" type="drug"/><pair e1="DrugDDI.d216.s14.e0" e2="DrugDDI.d216.s14.e1" id="DrugDDI.d216.s14.p0" interaction="true"/><pair e1="DrugDDI.d216.s14.e0" e2="DrugDDI.d216.s14.e2" id="DrugDDI.d216.s14.p1" interaction="true"/><pair e1="DrugDDI.d216.s14.e0" e2="DrugDDI.d216.s14.e3" id="DrugDDI.d216.s14.p2" interaction="true"/><pair e1="DrugDDI.d216.s14.e1" e2="DrugDDI.d216.s14.e2" id="DrugDDI.d216.s14.p3" interaction="false"/><pair e1="DrugDDI.d216.s14.e1" e2="DrugDDI.d216.s14.e3" id="DrugDDI.d216.s14.p4" interaction="false"/><pair e1="DrugDDI.d216.s14.e2" e2="DrugDDI.d216.s14.e3" id="DrugDDI.d216.s14.p5" interaction="false"/></sentence><sentence id="DrugDDI.d216.s15" origId="s15" text="In such patients, the mean area under the felodipine plasma concentration-time curve was also reduced to approximately 6% of that observed in healthy volunteers."><entity charOffset="42-52" id="DrugDDI.d216.s15.e0" origId="s15.p179" text="felodipine" type="drug"/></sentence><sentence id="DrugDDI.d216.s16" origId="s16" text="Since a clinically significant interaction may be anticipated, alternative antihypertensive therapy should be considered in these patients."><entity charOffset="75-91" id="DrugDDI.d216.s16.e0" origId="s16.p193" text="antihypertensive" type="drug"/></sentence><sentence id="DrugDDI.d216.s17" origId="s17" text="Tacrolimus? Felodipine may increase the blood concentration of tacrolimus."><entity charOffset="12-22" id="DrugDDI.d216.s17.e0" origId="s17.p198" text="Felodipine" type="drug"/><entity charOffset="63-73" id="DrugDDI.d216.s17.e1" origId="s17.p201" text="tacrolimus" type="drug"/><pair e1="DrugDDI.d216.s17.e0" e2="DrugDDI.d216.s17.e1" id="DrugDDI.d216.s17.p0" interaction="true"/></sentence><sentence id="DrugDDI.d216.s18" origId="s18" text="When given concomitantly with felodipine, the tacrolimus blood concentration should be followed and the tacrolimus dose may need to be adjusted."><entity charOffset="30-40" id="DrugDDI.d216.s18.e0" origId="s18.p205" text="felodipine" type="drug"/><entity charOffset="46-56" id="DrugDDI.d216.s18.e1" origId="s18.p206" text="tacrolimus" type="drug"/><pair e1="DrugDDI.d216.s18.e0" e2="DrugDDI.d216.s18.e1" id="DrugDDI.d216.s18.p0" interaction="true"/></sentence><sentence id="DrugDDI.d216.s19" origId="s19" text="Other Concomitant Therapy? In healthy subjects there were no clinically significant interactions when felodipine was given concomitantly with indomethacin or spironolactone."><entity charOffset="102-112" id="DrugDDI.d216.s19.e0" origId="s19.p222" text="felodipine" type="drug"/><entity charOffset="142-154" id="DrugDDI.d216.s19.e1" origId="s19.p225" text="indomethacin" type="drug"/><entity charOffset="158-172" id="DrugDDI.d216.s19.e2" origId="s19.p227" text="spironolactone" type="drug"/><pair e1="DrugDDI.d216.s19.e0" e2="DrugDDI.d216.s19.e1" id="DrugDDI.d216.s19.p0" interaction="false"/><pair e1="DrugDDI.d216.s19.e0" e2="DrugDDI.d216.s19.e2" id="DrugDDI.d216.s19.p1" interaction="false"/><pair e1="DrugDDI.d216.s19.e1" e2="DrugDDI.d216.s19.e2" id="DrugDDI.d216.s19.p2" interaction="false"/><negationtags>Other Concomitant Therapy? In healthy subjects there were &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; clinically significant interactions when felodipine was given concomitantly with indomethacin or spironolactone&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d216.s20" origId="s20" text="Interaction with Food? See CLINICAL PHARMACOLOGY, Pharmacokinetics and Metabolism."/></document>